Phase II study of conventional fractionated radiotherapy versus hyper-fractionated accelerated radiotherapy concomitant with low dose gemcitabine for patients with pancreatic cancer

Kousei Maemura,S. Takao,Hiroyuki Shinchi,Hidetoshi Noma,Yoshiyuki Hiraki,Masanori Nakajo,Takashi Aikou

Phase II study of conventional fractionated radiotherapy versus hyper-fractionated accelerated radiotherapy concomitant with low dose gemcitabine for patients with pancreatic cancer

2016

Kousei Maemura
S. Takao
Hiroyuki Shinchi
Hidetoshi Noma
Yoshiyuki Hiraki
Masanori Nakajo
Takashi Aikou

14017 Background: Concurrent radiotherapy and chemotherapy with gemcitabine (GEM) has been reported to improve the median survival of patients with unresectable pancreatic cancer. Although hyperfra...

Keywords:

Pathology
Phases of clinical research
Pancreatic cancer
Unresectable Pancreatic Cancer
Gemcitabine
Oncology
Radiation therapy
Chemotherapy
Medicine
Internal medicine
Concomitant
low dose
accelerated radiotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations